VI.3 DNA content in tamoxifen-induced endometrial carcinoma

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Moberger, B ^a   Fornander, T ^b   Hellstrom A C ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c Dept of Gynaecological Oncology ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TAMOXIFEN;

BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DNA ADDUCT; DNA CONTENT; ENDOMETRIUM CARCINOMA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 0345367511     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00121-X     Document Type: Conference Paper

References (8)

1. Fornander T, Cedermark B, Mattsson A, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989, 1, 117-120.
2. Neven P, De Muyleder X, Van Belle Y, Vanderick G, De Muylder E. Tamoxifen and the endometrium (Letter). Lancet 1989, 1, 375.
3. Malfetano M. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients. Gynecol Oncol 1990, 39, 82-84.
4. Hemminki K, Rajaniemi H, Lindahl B, Moberger B. Tamoxifen induced DNA-adducts in endometrial samples from breast cancer patients. Cancer Res 1996, 56, 4374-4377.
5. Moberger B, Auer G, Forsslund G, Moberger G. The prognostic significance of DNA measurements in endometrial carcinoma. Cytometry 1984, 5, 430-436.
6. Moberger B, Auer G, Einhorn N, Moberger G. The prognostic significance of growth pattern and its relation to tumour cells nuclear DNA content in endometrial carcinoma. Acta Oncol 29, Fasc 1989, 1, 17-23.
7. Iversen OE. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 1986, 155, 770-776.
8. Christopherson WM. The significance of the pathologic findings in endometrial cancer. Clin Obstet Gynaecol 1986, 13, 673-693.